Mesirow Financial Investment Management - Fixed Income’s Integra LifeSciences IART Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-131,530	Closed	-$5.88M	–	139
2020 Q1	$5.88M	Buy	131,530 +4,490	+4%	+$236K	1.4%	20
2019 Q4	$7.4M	Buy	+127,040	New	+$7.56M	1.15%	36
2019 Q3	–	Sell	-130,910	Closed	-$7.31M	–	128
2019 Q2	$7.31M	Sell	130,910 -51,675	-28%	-$2.66M	1.13%	44
2019 Q1	$10.2M	Buy	182,585 +155,275	+569%	+$7.91M	1.57%	11
2018 Q4	$1.23M	Buy	+27,310	New	+$1.5M	0.17%	89
2017 Q3	–	Sell	-25,125	Closed	-$1.37M	–	123
2017 Q2	$1.37M	Hold	25,125	–	–	0.09%	104
2017 Q1	$1.06M	Sell	25,125 -443,675	-95%	-$19M	0.07%	106
2016 Q4	$20.1M	Sell	468,800 -79,490	-14%	-$3.23M	1.24%	37
2016 Q3	$22.6M	Buy	548,290 +288,590	+111%	+$12.1M	1.33%	22
2016 Q2	$10.4M	Buy	+259,700	New	+$9.34M	0.6%	75

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's IART Position: Q2 2020 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 131,530 shares — an estimated $5.88M sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in IART in Q2 2016 and held it in 10 quarters. The position peaked at $22.6M in Q3 2016. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

Mesirow Financial Investment Management - Fixed Income reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 131,530 Integra LifeSciences shares in Q2 2020, an estimated $5.88M.
Mesirow Financial Investment Management - Fixed Income first reported a position in Integra LifeSciences in Q2 2016 and held it in 10 quarters.
Mesirow Financial Investment Management - Fixed Income's Integra LifeSciences position peaked at $22.6M in Q3 2016.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2020, filed 6 Aug 2020.